Effects of low-dose heparin infusion on arterial endothelin-1 release in humans

Circulation

Volumn 94, Issue 11, 1996, Pages 2703-2707

  Piatti, P M ^a,b   Monti, L D ^a   Valsecchi, G ^a   Conti, M ^a   Nasser, R ^a   Guazzini, B ^a   Fochesato, E ^a   Phan, C V ^a   Pontiroli, A E ^a   Pozza, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

endothelium derived factors; heparin; insulin

Indexed keywords

ENDOTHELIN 1; HEPARIN; INSULIN;

ADULT; ARTICLE; FEMALE; FOREARM BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEPARINIZATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION;

EID: 10544256596     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2703     Document Type: Article

References (40)

1. Yanagisawa MM, Kurihara Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cell. Nature. 1988;332:411-415.
2. Luscher TF, Boulanger CM, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension. 1992;19:117-130.
3. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
4. Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin-l in patients with essential hypertension. N Engl J Med. 1990;322:205.
5. Miyauchi T, Yanagishawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T. Increased plasma concentration of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet. 1989;2:53-54.
6. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis N Engl J Med. 1991;325:997-1001.
7. Haynes W, Webb DJ. Contribution of endogeneous generation of endothelin-1 to basal tone. Lancet. 1994;344:852-854.
8. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Endothelin in myocardial infarction. Nature. 1990;344:114.
9. Wang QD, Hemsén A, Li X-S, Lundberg JM, Uriuda Y, Pernow J. Local overflow and enhanced tissue content of endothelin following ischemia and reperfusion in the pig: modulation by L-arginine. Cardiovasc Res. 1995;29:44-49.
10. Neri Serneri GG, Rovelli F, Gensini GF, Pirelli S, Carnovali M, Fortini A. Effectiveness of low-dose heparin in prevention of myocardial infarction. Lancet. 1987;1:937-942.
11. Neri Serneri GG, Modesti PA, Gensini GF, Branzi A, Melandri G, Poggesi L, Rostagno C, Tamburini C, Carnovali M, Magnani B. Randomised comparison of subcutaneous heparin, intravenous heparin. and aspirin in unstable angina. Lancet. 1995;345:1201-1204.
12. Mant M, Thog KL, Birtwhistle RV, O'Brien BD, Hammond GW, Grace MG. Haemorragic complications of heparin therapy. Lancet. 1977;1:1133-1135.
13. Yokokawa K, Mandal AK, Kohno M, Horio T, Murakawa KI, Yasunari K, Takeda T. Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. Am J Physiol. 1992;263:R1035-R1041.
14. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagisawa M, Takeda T. Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest. 1993;92:2080-2085.
15. Yokokawa K, Kohno M, Tahara H, Mandal AK, Yasunari K, Murakawa K, Horio T, Ikeda M, Minami M, Takeda T. Effect of heparin on endothelin-1 production by cultured human endothelial cells. J Cardiovasc Pharmacol. 1993;22(suppl 8):S46-S48.
16. Thadani U,. Chiong MA, Parker JO. Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris. Circulation. 1980;61:266-276.
17. Whitiow PL, Rogers WJ, Smith LR, McDaniel HG, Papapietro HG, Papapietro SE, Mantle JA, Logic JR, Russel RO, Rackley CE. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol. 1994;49:811-820.
18. Haider W, Benzer H, Schutz W, Wolner E. Improvement of cardiac preservation by preoperative high insulin supply. J Thorac Cardiovasc Surg. 1984;88:294-300.
19. Anfossi G, Cavalot F, Massucco P, Mattiello L, Mularoni E, Hahn A, Travati M. Insulin influences immunoreactive endothelin release by vascular smooth muscle cells. Metabolism. 1993;42:1081-1083.
20. Olivert FJ, De la Rubia G, Feener EP, Lee ME, Locken MR, Shiba T, Quertermous T, King GL. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 1991;266:23251-23256.
21. Piatti PM, Monti LD, Conti M, Baruffaldi L, Galli L, Phan CV, Guazzini B, Pontiroli AE, Pozza G. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes. 1996;45:316-321.
22. Metsarinne K, Saijonmaa O, Yki-Jarvinen H, Fyhrquist F. Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo. Metabolism. 1994;43:878-882.
23. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, Demattia G, Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab. 1995;80:829-835.
24. Wolpert HA, Steen SN, Istfan NW, Simonson DC. Insulin modulates circulating endothelin-1 levels in humans. Metabolism. 1993;42:1027-1030.
25. De Fronzo RA, Tobin JD, Andres R. Glucose damp technique: a method for quanti lying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
26. Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE. Production of insulin resistance by hyperinsulinaemia in man. Diabetologia. 1985;28:70-75.
27. Monti LD, Brambilla P, Stefani I, Caumo A, Magni F, Poma R, Tomasini L, Agostini G, Galli-Kienle M, Cobelli C, Chiumello G, Pozza G. Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. Diabetologia. 1995;38:739-747.
28. Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4h in normal subjects. 1996;45:1364-1366.
29. Piatti PM, Monti LD, Pacchioni M, Pontiroli AE, Pozza G. Forearm insulin- and non-insulin-mediated glucose uptake in man: role of free fatty acids and blood glucose. Metabolism. 1991;40:926-933.
30. Verdon CP, Burton BA, Prior RL. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the griess reaction is used to assay for nitrite. Anal Biochem. 1995;224:502-508.
31. Foster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
32. Hagar JM. Endogenous endothelin-1 impairs endothelium-dependent relaxation after myocardial ischemia and reperfusion. Am J Physiol. 1994;36:H1833-H1841.
33. Guazzini B, Piatti PM, Monti LD, Santambrogio G, Valsecchi G, Phan CV, Fochesato E, Stangalini C, Cusin C, Pozza G, Pontiroli AE. Insulin induces an acute endothelin-1 but not nitric oxide release in hypertensive subjects. Eur J Clin Invest. 1996;26:42A. Abstract.
34. Vierhapper H, Wagner O, Nowotny P, Waldbausl W. Effect of endothelin-1 in man. Circulation. 1990;81:1415-1418.
35. Whitlow PL, Rogers WJ, Smith LR, Papapietro SE, Mantle JA, Logic JR, Russell RO, Rackley CE. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol. 1982;49:811-820.
36. Thadani U, Chiong MA, Parker JO. Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris. Circulation. 1980;61:266-276.
37. Gore JM, Sloan M, Price TR, Randal AMY, Bovil E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML. Intracerebral hemorrage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction study. Circulation. 1991;83:448-459.
38. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation. 1994;90:1631-1637.
39. Zehier AM, Ihling C, Pistorius K, Schachinger V, Schaefer HE. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet. 1994;344:1405-1406.
40. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation. 1994;89:1573-1579.